Selected research
Industry Growth & Trends
Global Gene Therapy Medicine Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Gene Therapy Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Gene Therapy Medicine market include Vical Inc., Spark Therapeutics, Sangamo, Dimension Therapeutics, Celladon, Bluebird Bio, Avalanche Bio and Advantagene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gene Therapy Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gene Therapy Medicine market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Therapy Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Therapy Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Gene Therapy Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gene Therapy Medicine Market by Company
Vical Inc.
Spark Therapeutics
Sangamo
Dimension Therapeutics
Celladon
Bluebird Bio
Avalanche Bio
Advantagene
Gene Therapy Medicine Segment by Type
Oral
Injection
Gene Therapy Medicine Segment by Application
Cancer
Infectious Disease
Monogenic
Cardiovascular Disease
Other
Gene Therapy Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Gene Therapy Medicine companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Cancer
- Infectious Disease
- Monogenic
- Cardiovascular Disease
- Other
Companies covered
- Vical Inc.
- Spark Therapeutics
- Sangamo
- Dimension Therapeutics
- Celladon
- Bluebird Bio
- Avalanche Bio
- Advantagene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Gene Therapy Medicine Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Gene Therapy Medicine Market Size by Region (2021-2032)
- 1.4.1 Global Gene Therapy Medicine Market Size by Region (2021-2026)
- 1.4.2 Global Gene Therapy Medicine Market Size by Region (2027-2032)
- 1.5 Key Regions Gene Therapy Medicine Market Size (2021-2032)
- 1.5.1 North America Gene Therapy Medicine Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Gene Therapy Medicine Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Gene Therapy Medicine Market Size Growth Rate (2021-2032)
- 1.5.4 South America Gene Therapy Medicine Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Gene Therapy Medicine Market Size Growth Rate (2021-2032)
2 Gene Therapy Medicine Market by Type
- 2.1 Type Introduction
- 2.1.1 Oral
- 2.1.2 Injection
- 2.2 Global Gene Therapy Medicine Market Size by Type
- 2.2.1 Global Gene Therapy Medicine Market Size Overview by Type (2021-2032)
- 2.2.2 Global Gene Therapy Medicine Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Gene Therapy Medicine Market Size Forecasted by Type (2027-2032)
- 2.3 Global Gene Therapy Medicine Market Size by Regions
- 2.3.1 North America Gene Therapy Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Gene Therapy Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Gene Therapy Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Gene Therapy Medicine Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Gene Therapy Medicine Market Size Breakdown by Type (2021-2026)
3 Gene Therapy Medicine Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Infectious Disease
- 3.1.3 Monogenic
- 3.1.4 Cardiovascular Disease
- 3.1.5 Other
- 3.2 Global Gene Therapy Medicine Market Size by Application
- 3.2.1 Global Gene Therapy Medicine Market Size Overview by Application (2021-2032)
- 3.2.2 Global Gene Therapy Medicine Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Gene Therapy Medicine Market Size Forecasted by Application (2027-2032)
- 3.3 Global Gene Therapy Medicine Market Size by Regions
- 3.3.1 North America Gene Therapy Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Gene Therapy Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Gene Therapy Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Gene Therapy Medicine Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Gene Therapy Medicine Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Gene Therapy Medicine Industry Trends
- 4.2 Gene Therapy Medicine Industry Drivers
- 4.3 Gene Therapy Medicine Industry Opportunities and Challenges
- 4.4 Gene Therapy Medicine Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Gene Therapy Medicine Revenue (2021-2026)
- 5.2 Global Gene Therapy Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Gene Therapy Medicine Key Company Headquarters & Area Served
- 5.4 Global Gene Therapy Medicine Company, Product Type & Application
- 5.5 Global Gene Therapy Medicine Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Gene Therapy Medicine Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Gene Therapy Medicine Players Market Share by Revenue in 2025
- 5.6.3 2025 Gene Therapy Medicine Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Vical Inc.
- 6.1.1 Vical Inc. Company Information
- 6.1.2 Vical Inc. Business Overview
- 6.1.3 Vical Inc. Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Vical Inc. Gene Therapy Medicine Product Portfolio
- 6.1.5 Vical Inc. Recent Developments
- 6.2 Spark Therapeutics
- 6.2.1 Spark Therapeutics Company Information
- 6.2.2 Spark Therapeutics Business Overview
- 6.2.3 Spark Therapeutics Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Spark Therapeutics Gene Therapy Medicine Product Portfolio
- 6.2.5 Spark Therapeutics Recent Developments
- 6.3 Sangamo
- 6.3.1 Sangamo Company Information
- 6.3.2 Sangamo Business Overview
- 6.3.3 Sangamo Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sangamo Gene Therapy Medicine Product Portfolio
- 6.3.5 Sangamo Recent Developments
- 6.4 Dimension Therapeutics
- 6.4.1 Dimension Therapeutics Company Information
- 6.4.2 Dimension Therapeutics Business Overview
- 6.4.3 Dimension Therapeutics Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Dimension Therapeutics Gene Therapy Medicine Product Portfolio
- 6.4.5 Dimension Therapeutics Recent Developments
- 6.5 Celladon
- 6.5.1 Celladon Company Information
- 6.5.2 Celladon Business Overview
- 6.5.3 Celladon Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Celladon Gene Therapy Medicine Product Portfolio
- 6.5.5 Celladon Recent Developments
- 6.6 Bluebird Bio
- 6.6.1 Bluebird Bio Company Information
- 6.6.2 Bluebird Bio Business Overview
- 6.6.3 Bluebird Bio Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bluebird Bio Gene Therapy Medicine Product Portfolio
- 6.6.5 Bluebird Bio Recent Developments
- 6.7 Avalanche Bio
- 6.7.1 Avalanche Bio Company Information
- 6.7.2 Avalanche Bio Business Overview
- 6.7.3 Avalanche Bio Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Avalanche Bio Gene Therapy Medicine Product Portfolio
- 6.7.5 Avalanche Bio Recent Developments
- 6.8 Advantagene
- 6.8.1 Advantagene Company Information
- 6.8.2 Advantagene Business Overview
- 6.8.3 Advantagene Gene Therapy Medicine Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Advantagene Gene Therapy Medicine Product Portfolio
- 6.8.5 Advantagene Recent Developments
7 North America
- 7.1 North America Gene Therapy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Gene Therapy Medicine Market Size by Country (2021-2026)
- 7.3 North America Gene Therapy Medicine Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Gene Therapy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Gene Therapy Medicine Market Size by Country (2021-2026)
- 8.3 Europe Gene Therapy Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Therapy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Gene Therapy Medicine Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Gene Therapy Medicine Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Gene Therapy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Gene Therapy Medicine Market Size by Country (2021-2026)
- 10.3 South America Gene Therapy Medicine Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Therapy Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Gene Therapy Medicine Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Gene Therapy Medicine Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst